Last year, Congress considered limits on direct to consumer (DTC) prescription drug advertising (about which we wrote here), but this effort stalled. A recent letter from two Congressional leaders of the Energy and Commerce Committee suggest that Congress is looking at these issues once again. This advertising has become important to television networks, and to drug